Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

508 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Anetumab Biosimilar(Anti-­Mesothelin Reference Antibody) Other DCC-A343-5mg

DCChemicals
5 mg Login
Compare
Anetumab Biosimilar(Anti-­Mesothelin Reference Antibody) Other DCC-A343-10mg

DCChemicals
10 mg Login
Compare
NIH patent anti-­Mesothelin Biosimilar(Anti-­Mesothelin Reference Antibody) Other DCC-A344-1mg

DCChemicals
1 mg Login
Compare
NIH patent anti-­Mesothelin Biosimilar(Anti-­Mesothelin Reference Antibody) Other DCC-A344-5mg

DCChemicals
5 mg Login
Compare
NIH patent anti-­Mesothelin Biosimilar(Anti-­Mesothelin Reference Antibody) Other DCC-A344-10mg

DCChemicals
10 mg Login
Compare
BMS patent anti-­Integrin α5β1 Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Other DCC-A293-1mg

DCChemicals
1 mg Login
Compare
BMS patent anti-­Integrin α5β1 Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Other DCC-A293-5mg

DCChemicals
5 mg Login
Compare
BMS patent anti-­Integrin α5β1 Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Other DCC-A293-10mg

DCChemicals
10 mg Login
Compare
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A151-1mg

DCChemicals
1 mg Login
Compare
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A151-5mg

DCChemicals
5 mg Login
Compare
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A151-10mg

DCChemicals
10 mg Login
Compare
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A152-1mg

DCChemicals
1 mg Login
Compare
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A152-5mg

DCChemicals
5 mg Login
Compare
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Other DCC-A152-10mg

DCChemicals
10 mg Login
Compare
Raludotatug Biosimilar(Anti-­CDH6 /­ K-­Cadherin Reference Antibody) Other DCC-A1037-1mg

DCChemicals
1 mg Login
Compare
Raludotatug Biosimilar(Anti-­CDH6 /­ K-­Cadherin Reference Antibody) Other DCC-A1037-5mg

DCChemicals
5 mg Login
Compare
Raludotatug Biosimilar(Anti-­CDH6 /­ K-­Cadherin Reference Antibody) Other DCC-A1037-10mg

DCChemicals
10 mg Login
Compare
Radretumab Biosimilar(Anti-­Fibronectin Reference Antibody) Other DCC-A107-1mg

DCChemicals
1 mg Login
Compare
Radretumab Biosimilar(Anti-­Fibronectin Reference Antibody) Other DCC-A107-5mg

DCChemicals
5 mg Login
Compare
Radretumab Biosimilar(Anti-­Fibronectin Reference Antibody) Other DCC-A107-10mg

DCChemicals
10 mg Login
Compare
L19-­TNF Biosimilar(Anti-­Fibronectin Reference Antibody) Other DCC-A108-1mg

DCChemicals
1 mg Login
Compare
L19-­TNF Biosimilar(Anti-­Fibronectin Reference Antibody) Other DCC-A108-5mg

DCChemicals
5 mg Login
Compare
L19-­TNF Biosimilar(Anti-­Fibronectin Reference Antibody) Other DCC-A108-10mg

DCChemicals
10 mg Login
Compare
TNF-­α-­IN-­9 Inhibitors Other DCC-DC65509-100mg

DCChemicals
100 mg Login
Compare
TNF-­α-­IN-­9 Inhibitors Other DCC-DC65509-250mg

DCChemicals
250 mg Login
Compare
Name Price
Anetumab Biosimilar(Anti-­Mesothelin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Anetumab Biosimilar(Anti-­Mesothelin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
NIH patent anti-­Mesothelin Biosimilar(Anti-­Mesothelin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
NIH patent anti-­Mesothelin Biosimilar(Anti-­Mesothelin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
NIH patent anti-­Mesothelin Biosimilar(Anti-­Mesothelin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
BMS patent anti-­Integrin α5β1 Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
BMS patent anti-­Integrin α5β1 Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
BMS patent anti-­Integrin α5β1 Biosimilar(Anti-­Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Codrituzumab Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Codrituzumab-­MMAE Biosimilar(Anti-­GPC3 /­ Glypican-­3 Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
Raludotatug Biosimilar(Anti-­CDH6 /­ K-­Cadherin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
Raludotatug Biosimilar(Anti-­CDH6 /­ K-­Cadherin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Raludotatug Biosimilar(Anti-­CDH6 /­ K-­Cadherin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
Radretumab Biosimilar(Anti-­Fibronectin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
Radretumab Biosimilar(Anti-­Fibronectin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Radretumab Biosimilar(Anti-­Fibronectin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
L19-­TNF Biosimilar(Anti-­Fibronectin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
L19-­TNF Biosimilar(Anti-­Fibronectin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
L19-­TNF Biosimilar(Anti-­Fibronectin Reference Antibody) Login
Type
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
TNF-­α-­IN-­9 Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
TNF-­α-­IN-­9 Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 250 mg
Available

508 Item(s)

per page